Stock Comparison

Bristol-Myers Squibb Company
vs
 
Pfizer Inc.
 
Bristol-Myers Squibb Company
vs
Pfizer Inc.
Performance Comparison
Financial Metrics
BMY Metrics PFE
$45.98 Price $23.81
94.56 Billion Market Cap 136.91 Billion
17.45 Price to Earnings Ratio 17.41
5.42 Price to Book Ratio 1.51
1.99 Price to Sales 2.19
7.23 Price to Cash Flow Ratio 12.2
-5.6% Revenue Annual Growth -7.82%
-120.62% Income Annual Growth -4.75%
72.92% Gross Profit Margin 79.26%
21.93% Net Profit Margin 21.63%

-11.59

-11
Underperform
Outperform
Flagship Model Recommendation
41.06
41
Underperform
Outperform
Recommendation Summary

Stock BMY is projected to underperform the market, stock PFE is projected to outperform the market. Upfront Recommendation: PFE.